Botulinum toxin for the management of bruxism: an overview of reviews protocol.

ABSTRACT:

Introduction

Bruxism is characterised by a repetitive activity in the masticatory muscles that involves teeth clenching or grinding and/or forceful mandibular movements. Its management is typically initiated when individuals start experiencing the adverse effects of the condition. One of the available intervention forms is the administration of botulinum toxin type A (BoNT-A). Numerous systematic reviews have addressed the use of BoNT-A to manage bruxism; however, the results are controversial. The current overview aims to determine BoNT-A's effectiveness for managing bruxism in relation to placebo, the absence of treatment or alternative interventions in the adult population.

Methods and analysis

This study will include systematic reviews (SRs), with or without meta-analysi

SUBMITTER: Coelho MS 

PROVIDER: S-EPMC11474840 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature